Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity

Molecular Psychiatry

Volumn 6, Issue 5, 2001, Pages 586-592

  Serretti, A ^a   Zanardi, R ^a   Rossini, D ^a   Cusin, C ^a   Lilli, R ^a   Smeraldi, E ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Antidepressant treatment; Fluvoxamine; Mood disorders; Pindolol; Serotonin transporter; Tryptophan hydroxylase

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE; PINDOLOL; TRYPTOPHAN HYDROXYLASE;

ADULT; ALLELE; ARTICLE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RATING SCALE; RECEPTOR BLOCKING; SEROTONIN RELEASE;

ADULT; AGE OF ONSET; ALLELES; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; CARRIER PROTEINS; DELUSIONS; DEPRESSIVE DISORDER; DRUG SYNERGISM; FEMALE; FLUVOXAMINE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PINDOLOL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TRYPTOPHAN HYDROXYLASE; VARIATION (GENETICS);

EID: 0034885170     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000876     Document Type: Article

References (65)

1. Pharmacogenetic response to antidepressants in a multicase family with affective disorder
2. Differentiation of two genetically specific types of depression by the response to antidepressant
3. Depression
4. Antidepressant responses and segregation analyses in affective families
5. Mode of inheritance in mood disorders families according to fluvoxamine response
6. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
7. Progress and pitfalls: Bipolar molecular linkage studies
8. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
9. Allelic variation of human serotonin trasporter gene expression
10. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
11. Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression
12. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene
13. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
14. Polygenic inheritance in psychiatric disorders
15. Linkage strategies for genetically complex traits: I. Multilocus models
16. Who's afraid of epistasis?
17. L-tryptophan in neuropsychiatric disorders: A review
18. Potentiation of the antidepressant action of clomipramine by tryptophan
19. Use of tryptophan in combination with other antidepressant treatments: A review
20. Relapse of depression after rapid depletion of tryptophan
21. Complete coding sequence of human tryptophan hydroxylase
22. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p 15.3-p14 by in situ hybridization
23. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7
24. Tryptophan hydroxylase and catechol-O-methyl-transferase gene polymorphisms: Relationships to monoamine metabolite concentrations in CSF of healthy volunteers
25. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression
26. Nature, nurture and affective disorder
27. A family study of manic-depressive (bipolar I) disease. Is it a distinct illness separable from primary unipolar depression?
28. Serotonin transporter gene polymorphism and antidepressant response
29. Serotonin transporter gene polymorphisms: Ethnic difference and possible association with bipolar affective disorder
30. Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism
31. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))
32. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families
33. Association between the tryptophan hydroxylase gene and manic-depressive illness
34. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways
35. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder
36. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients
37. No allelic association between bipolar affective disorder and the tryptophan hydroxylase gene
38. Genetic association analysis of serotonin system genes in bipolar affective disorder
39. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors
40. Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controls
41. The 5′ region of the tryptophan hydroxylase gene: Mutation search and association study with alcoholism
42. No coding variant of tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism
43. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior
44. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways
45. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism
46. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients
47. Suicidal behaviors and the tryptophan hydroxylase gene
48. Tryptophan hydroxylase polymorphisms in suicide victims
49. TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population
50. Search for association between suicide attempt and serotonergic polymorphisms
51. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene
52. Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH)
53. Best estimate of lifetime psychiatric diagnosis: A methodological study
54. Development of a rating scale for primary depressive illness
55. Scales for assessment of diagnosis and severity of mental disorders
56. A comparison between delusional and non-delusional depressives
57. Psychomotor symptoms of depression
58. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor
59. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
60. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset
61. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
62. Patterns of symptom improvement during antidepressant treatment of delusional depression
63. MIXREG: A computer program for mixed-effects regression analysis with autocorrelated errors